• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中的交感神经过度活跃:后果与机制

Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms.

作者信息

Kaur Jasdeep, Young Benjamin E, Fadel Paul J

机构信息

Department of Kinesiology, University of Texas at Arlington, Arlington, TX 76019, USA.

出版信息

Int J Mol Sci. 2017 Aug 2;18(8):1682. doi: 10.3390/ijms18081682.

DOI:10.3390/ijms18081682
PMID:28767097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5578072/
Abstract

The incidence of chronic kidney disease (CKD) is increasing worldwide, with more than 26 million people suffering from CKD in the United States alone. More patients with CKD die of cardiovascular complications than progress to dialysis. Over 80% of CKD patients have hypertension, which is associated with increased risk of cardiovascular morbidity and mortality. Another common, perhaps underappreciated, feature of CKD is an overactive sympathetic nervous system. This elevation in sympathetic nerve activity (SNA) not only contributes to hypertension but also plays a detrimental role in the progression of CKD independent of any increase in blood pressure. Indeed, high SNA is associated with poor prognosis and increased cardiovascular morbidity and mortality independent of its effect on blood pressure. This brief review will discuss some of the consequences of sympathetic overactivity and highlight some of the potential pathways contributing to chronically elevated SNA in CKD. Mechanisms leading to chronic sympathoexcitation in CKD are complex, multifactorial and to date, not completely understood. Identification of the mechanisms and/or signals leading to sympathetic overactivity in CKD are crucial for development of effective therapeutic targets to reduce the increased cardiovascular risk in this patient group.

摘要

慢性肾脏病(CKD)的发病率在全球范围内呈上升趋势,仅在美国就有超过2600万人患有CKD。死于心血管并发症的CKD患者多于进展到透析阶段的患者。超过80%的CKD患者患有高血压,这与心血管疾病发病率和死亡率的增加有关。CKD的另一个常见但可能未得到充分认识的特征是交感神经系统过度活跃。交感神经活动(SNA)的这种升高不仅导致高血压,而且在CKD进展中独立于任何血压升高发挥有害作用。事实上,高SNA与不良预后以及心血管疾病发病率和死亡率增加有关,而与其对血压的影响无关。本简要综述将讨论交感神经活动过度的一些后果,并强调一些导致CKD中SNA长期升高的潜在途径。导致CKD中慢性交感神经兴奋的机制复杂、多因素,迄今为止尚未完全了解。确定导致CKD中交感神经活动过度的机制和/或信号对于开发有效的治疗靶点以降低该患者群体增加的心血管风险至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/887eb1a928a3/ijms-18-01682-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/0f1c5f69f574/ijms-18-01682-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/b625335a0c82/ijms-18-01682-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/e4bd5db4bfeb/ijms-18-01682-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/3d1a85686b7c/ijms-18-01682-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/887eb1a928a3/ijms-18-01682-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/0f1c5f69f574/ijms-18-01682-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/b625335a0c82/ijms-18-01682-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/e4bd5db4bfeb/ijms-18-01682-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/3d1a85686b7c/ijms-18-01682-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc93/5578072/887eb1a928a3/ijms-18-01682-g005.jpg

相似文献

1
Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms.慢性肾脏病中的交感神经过度活跃:后果与机制
Int J Mol Sci. 2017 Aug 2;18(8):1682. doi: 10.3390/ijms18081682.
2
Selective afferent renal denervation mitigates renal and splanchnic sympathetic nerve overactivity and renal function in chronic kidney disease-induced hypertension.选择性内脏去肾神经支配可减轻慢性肾脏病相关高血压患者的肾脏和内脏交感神经活性亢进及肾功能障碍。
J Hypertens. 2020 Apr;38(4):765-773. doi: 10.1097/HJH.0000000000002304.
3
Sympathetic overactivity in uremia.尿毒症中的交感神经过度活跃。
J Ren Nutr. 2008 Jan;18(1):118-21. doi: 10.1053/j.jrn.2007.10.024.
4
Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment.慢性肾脏病中的交感神经过度活跃:发病机制、临床相关性及治疗
Kidney Int. 2004 May;65(5):1568-76. doi: 10.1111/j.1523-1755.2004.00552.x.
5
Potential role of endurance training in altering renal sympathetic nerve activity in CKD?耐力训练在改变慢性肾脏病患者肾交感神经活性方面的潜在作用?
Auton Neurosci. 2017 May;204:74-80. doi: 10.1016/j.autneu.2016.11.002. Epub 2016 Nov 25.
6
Cause and consequences of sympathetic hyperactivity in chronic kidney disease.慢性肾脏病中交感神经过度活跃的原因及后果。
Blood Purif. 2006;24(1):95-9. doi: 10.1159/000089444.
7
Contribution of the Renal Nerves to Hypertension in a Rabbit Model of Chronic Kidney Disease.肾脏神经在慢性肾脏病兔模型高血压中的作用。
Hypertension. 2020 Nov;76(5):1470-1479. doi: 10.1161/HYPERTENSIONAHA.120.15769. Epub 2020 Sep 8.
8
Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?尿毒症:慢性肾脏病中心神经体液功能障碍的一个未被认识到的驱动因素?
Acta Physiol (Oxf). 2017 Jan;219(1):305-323. doi: 10.1111/apha.12727. Epub 2016 Jun 23.
9
Total renal denervation reduces sympathoexcitation to different target organs in a model of chronic kidney disease.在慢性肾病模型中,完全肾去神经支配可降低对不同靶器官的交感神经兴奋。
Auton Neurosci. 2017 May;204:81-87. doi: 10.1016/j.autneu.2016.11.006. Epub 2016 Dec 1.
10
Renal denervation enhances GABA-ergic input into the PVN leading to blood pressure lowering in chronic kidney disease.肾去神经支配增强了向室旁核的γ-氨基丁酸能输入,从而导致慢性肾病患者血压降低。
Auton Neurosci. 2017 May;204:88-97. doi: 10.1016/j.autneu.2016.09.018. Epub 2016 Oct 4.

引用本文的文献

1
Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms-a comprehensive review.心血管-肾脏-代谢综合征中的炎症:关键作用及潜在机制——综述
Mol Cell Biochem. 2025 Sep 10. doi: 10.1007/s11010-025-05379-9.
2
Safety and Efficacy of Renal Denervation for the Treatment of Resistant Hypertension in Patients with Chronic Kidney Disease: A Narrative Review of the Literature.肾脏去神经支配治疗慢性肾脏病患者顽固性高血压的安全性和有效性:文献综述
Biomedicines. 2025 Aug 9;13(8):1951. doi: 10.3390/biomedicines13081951.
3
An investigation of the Effect of Antihypertensive drugs on Arteriovenous Fistula Maturation in Patients with Hemodialysis.

本文引用的文献

1
Uremia induces adipose tissue inflammation and muscle mitochondrial dysfunction.尿毒症引起脂肪组织炎症和肌肉线粒体功能障碍。
Nephrol Dial Transplant. 2017 Jun 1;32(6):943-951. doi: 10.1093/ndt/gfx050.
2
Effects of statin therapy on cerebrovascular and renal outcomes in patients with predialysis advanced chronic kidney disease and dyslipidemia.他汀类药物治疗对透析前晚期慢性肾脏病合并血脂异常患者脑血管和肾脏预后的影响。
J Clin Lipidol. 2017 Mar-Apr;11(2):422-431.e2. doi: 10.1016/j.jacl.2017.01.001. Epub 2017 Jan 21.
3
Meta-analysis of statins in chronic kidney disease: who benefits?
抗高血压药物对血液透析患者动静脉内瘘成熟影响的研究
Caspian J Intern Med. 2025 Jun 23;16(3):500-506. doi: 10.22088/cjim.16.3.500. eCollection 2025 Summer.
4
Cardiovascular Risk and Its Presentation in Chronic Kidney Disease.心血管风险及其在慢性肾脏病中的表现
J Clin Med. 2025 Jun 27;14(13):4567. doi: 10.3390/jcm14134567.
5
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease.肾去神经支配对合并及不合并慢性肾脏病的高血压患者糖代谢的影响。
Clin Kidney J. 2025 Jun 18;18(7):sfaf184. doi: 10.1093/ckj/sfaf184. eCollection 2025 Jul.
6
The relationship between homocysteine levels and blood pressure variability with early renal injury marker NGAL in patients with H-type hypertension.H型高血压患者中同型半胱氨酸水平及血压变异性与早期肾损伤标志物中性粒细胞明胶酶相关脂质运载蛋白的关系。
BMC Cardiovasc Disord. 2025 Jun 8;25(1):439. doi: 10.1186/s12872-025-04883-6.
7
Association between heart rate fragmentation and kidney function decline in MESA: evidence consistent with parasympathetic degradation.动脉粥样硬化多民族研究中心率变异性与肾功能下降之间的关联:与副交感神经功能退化一致的证据
Am J Physiol Regul Integr Comp Physiol. 2025 Jul 1;329(1):R186-R194. doi: 10.1152/ajpregu.00091.2025. Epub 2025 May 30.
8
Renal-Cardiac Crosstalk in the Pathogenesis and Progression of Heart Failure.心力衰竭发病机制与进展中的肾心交互作用
Circ Res. 2025 May 23;136(11):1306-1334. doi: 10.1161/CIRCRESAHA.124.325488. Epub 2025 May 22.
9
Sodium-glucose co-transporter 2 inhibitors: Prospects for canine myxomatous mitral valve disease and finding the "right drug" and the "right dose" for dogs.钠-葡萄糖协同转运蛋白2抑制剂:犬黏液瘤性二尖瓣疾病的前景以及为犬找到“正确的药物”和“正确的剂量”
J Vet Med Sci. 2025 Jun 1;87(6):647-666. doi: 10.1292/jvms.25-0040. Epub 2025 Apr 16.
10
The Kidney-Immune-Brain Axis: The Role of Inflammation in the Pathogenesis and Treatment of Stroke in Chronic Kidney Disease.肾-免疫-脑轴:炎症在慢性肾脏病中风发病机制及治疗中的作用
Stroke. 2025 Apr;56(4):1069-1081. doi: 10.1161/STROKEAHA.124.047070. Epub 2025 Jan 24.
他汀类药物在慢性肾脏病中的荟萃分析:谁受益?
QJM. 2017 Aug 1;110(8):493-500. doi: 10.1093/qjmed/hcx040.
4
Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge.阻断自发性高血压大鼠延髓头端腹外侧区的血管紧张素AT1受体可降低血压并减少交感神经放电。
J Renin Angiotensin Aldosterone Syst. 2001 Mar;2(1_suppl):S120-S124. doi: 10.1177/14703203010020012101.
5
Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease.循环血管紧张素转化酶 2 活性作为慢性肾脏病患者无症状动脉粥样硬化的生物标志物。
Atherosclerosis. 2016 Oct;253:135-143. doi: 10.1016/j.atherosclerosis.2016.08.032. Epub 2016 Aug 24.
6
The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.不对称二甲基精氨酸(ADMA)和L-精氨酸与人血脑屏障在体外的转运体及通透性相互作用。
Brain Res. 2016 Oct 1;1648(Pt A):232-242. doi: 10.1016/j.brainres.2016.07.026. Epub 2016 Jul 16.
7
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.《美国肾脏数据系统2015年年报:美国肾脏疾病流行病学》
Am J Kidney Dis. 2016 Mar;67(3 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.12.014.
8
United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease.美国肾脏数据系统对慢性肾脏病和终末期肾病的公共卫生监测。
Kidney Int Suppl (2011). 2015 Jun;5(1):2-7. doi: 10.1038/kisup.2015.2.
9
Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis.他汀类药物与慢性肾脏病的心血管一级预防:一项荟萃分析。
Clin J Am Soc Nephrol. 2015 May 7;10(5):732-9. doi: 10.2215/CJN.07460714. Epub 2015 Apr 1.
10
The effect of statins on sympathetic activity: a meta-analysis.他汀类药物对交感神经活动的影响:一项荟萃分析。
Clin Auton Res. 2015 Apr;25(2):125-31. doi: 10.1007/s10286-015-0274-1. Epub 2015 Mar 5.